These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12508160)

  • 21. Cidofovir in the treatment of HPV-associated lesions.
    Snoeck R; Andrei G; De Clercq E
    Verh K Acad Geneeskd Belg; 2001; 63(2):93-120, discussion 120-2. PubMed ID: 11436421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dissection of the Kaposi's sarcoma-associated herpesvirus gene expression program by using the viral DNA replication inhibitor cidofovir.
    Lu M; Suen J; Frias C; Pfeiffer R; Tsai MH; Chuang E; Zeichner SL
    J Virol; 2004 Dec; 78(24):13637-52. PubMed ID: 15564474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resolution of recalcitrant molluscum contagiosum virus lesions in human immunodeficiency virus-infected patients treated with cidofovir.
    Meadows KP; Tyring SK; Pavia AT; Rallis TM
    Arch Dermatol; 1997 Aug; 133(8):987-90. PubMed ID: 9267245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resolution of recalcitrant human papillomavirus gingival infection with topical cidofovir.
    Calista D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Dec; 90(6):713-5. PubMed ID: 11113816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New drug targets in Kaposi sarcoma.
    Sullivan RJ; Pantanowitz L
    Expert Opin Ther Targets; 2010 Dec; 14(12):1355-66. PubMed ID: 21043836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KSHV viral load and Interleukin-6 in HIV-associated pediatric Kaposi sarcoma-Exploring the role of lytic activation in driving the unique clinical features seen in endemic regions.
    El-Mallawany NK; Mehta PS; Kamiyango W; Villiera J; Peckham-Gregory EC; Kampani C; Krysiak R; Sanders MK; Caro-Vegas C; Eason AB; Ahmed S; Schutze GE; Martin SC; Kazembe PN; Scheurer ME; Dittmer DP
    Int J Cancer; 2019 Jan; 144(1):110-116. PubMed ID: 30204240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I study of combination therapy with intravenous cidofovir and oral ganciclovir for cytomegalovirus retinitis in patients with AIDS.
    Jacobson MA; Wilson S; Stanley H; Holtzer C; Cherrington J; Safrin S
    Clin Infect Dis; 1999 Mar; 28(3):528-33. PubMed ID: 10194072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
    Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
    AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A review of topical and intralesional cidofovir.
    Zabawski EJ
    Dermatol Online J; 2000 Sep; 6(1):3. PubMed ID: 11328613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative changes in cytomegalovirus DNAemia and genetic analysis of the UL97 and UL54 genes in AIDS patients receiving cidofovir following ganciclovir therapy.
    Bowen EF; Cherrington JM; Lamy PD; Griffiths PD; Johnson MA; Emery VC
    J Med Virol; 1999 Aug; 58(4):402-7. PubMed ID: 10421408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous cidofovir for compassionate use in AIDS patients with cytomegalovirus retinitis. Spanish Cidofovir Study Group.
    Berenguer J; Mallolas J
    Clin Infect Dis; 2000 Jan; 30(1):182-4. PubMed ID: 10619750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anterior uveitis and hypotony after intravenous cidofovir for the treatment of cytomegalovirus retinitis.
    Akler ME; Johnson DW; Burman WJ; Johnson SC
    Ophthalmology; 1998 Apr; 105(4):651-7. PubMed ID: 9544639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated virus loads of Kaposi's sarcoma-associated human herpesvirus 8 predict Kaposi's sarcoma disease progression, but elevated levels of human immunodeficiency virus type 1 do not.
    Quinlivan EB; Zhang C; Stewart PW; Komoltri C; Davis MG; Wehbie RS
    J Infect Dis; 2002 Jun; 185(12):1736-44. PubMed ID: 12085319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for a multiclonal origin of multicentric advanced lesions of Kaposi sarcoma.
    Duprez R; Lacoste V; Brière J; Couppié P; Frances C; Sainte-Marie D; Kassa-Kelembho E; Lando MJ; Essame Oyono JL; Nkegoum B; Hbid O; Mahé A; Lebbé C; Tortevoye P; Huerre M; Gessain A
    J Natl Cancer Inst; 2007 Jul; 99(14):1086-94. PubMed ID: 17623796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishment and cidofovir sensitivity of a cell line from a heart transplant recipient with multiple cutaneous tumors.
    Schacke M; Meerbach A; Thust R; Hyckel P; Wutzler P
    Neoplasma; 2003; 50(3):165-71. PubMed ID: 12937848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
    Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
    Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective study of the effects of antiretroviral therapy on Kaposi sarcoma--associated herpesvirus infection in patients with and without Kaposi sarcoma.
    Gill J; Bourboulia D; Wilkinson J; Hayes P; Cope A; Marcelin AG; Calvez V; Gotch F; Boshoff C; Gazzard B
    J Acquir Immune Defic Syndr; 2002 Dec; 31(4):384-90. PubMed ID: 12447008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies.
    Abdulkarim B; Sabri S; Zelenika D; Deutsch E; Frascogna V; Klijanienko J; Vainchenker W; Joab I; Bourhis J
    Oncogene; 2003 Apr; 22(15):2260-71. PubMed ID: 12700662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral treatment of murine cytomegalovirus infections with ether lipid esters of cidofovir.
    Kern ER; Collins DJ; Wan WB; Beadle JR; Hostetler KY; Quenelle DC
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3516-22. PubMed ID: 15328119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Failure of cidofovir therapy in progressive multifocal leukoencephalopathy unrelated to human immunodeficiency virus.
    Houston S; Roberts N; Mashinter L
    Clin Infect Dis; 2001 Jan; 32(1):150-2. PubMed ID: 11112674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.